Skip to main content

WHERE MEDICAL INNOVATIONS TAKE FLIGHT

The importance of rigorous ACT management during preclinical study procedures

During the preclinical testing of medical devices, one data point that regulatory officials are scrutinizing is the activated clotting time (ACT) of the animal model. ACTs are measured periodically while an invasive device is inserted in the vasculature This allows lab staff to monitor clotting time before and after the anti-coagulant (e.g. heparin) has been […]

Read More